CVS Health Corp (CVS)

CVS Health (NYSE: CVS) is far more than a retail pharmacy chain - it is one of the largest integrated healthcare companies in the United States, spanning health insurance (Aetna), pharmacy benefit management/PBM (Caremark), and over 9,000 retail pharmacy locations nationwide. To understand CVS today, you first need to understand the story behind its stock price.

Throughout 2024-2025, CVS went through a severe crisis. Medical costs within the Aetna segment (particularly Medicare Advantage plans) ran far ahead of collected premiums - in industry terms, the medical loss ratio (MLR) blew out. This drove heavy losses from the insurance segment, and the stock fell to a 52-week low around $58.99.

2026 is shaping up as the turnaround year. Q1 2026 results showed Aetna's MLR back under control at 84.6%, adjusted EPS beat expectations at $2.57, and management has now raised full-year EPS guidance twice, to $7.30-$7.50. This is what propelled CVS stock to an all-time-high close ($110.60 on July 21, 2026) after months of recovery from the lows.

Business Segment Breakdown (Q1 2026)

• Health Services (~50% of revenue) - the largest segment, covering Caremark (PBM) and specialty pharmacy. Revenue of $48.24B, up +11% YoY - the company's primary growth engine right now.
• Pharmacy & Consumer Wellness (~20% of revenue) - retail pharmacy and front-store sales. Revenue of $31.99B, roughly flat YoY - structural pressure post-COVID, but stabilizing.
• Health Care Benefits / Aetna (remainder of revenue) - the health insurance segment behind the 2024-2025 crisis, now the central character in the recovery story with a much more controlled MLR.

⚠️ Shariah Status: NON-COMPLIANT

CVS Health is classified as NON-COMPLIANT under standard Shariah screening. Two core reasons:

• Core business includes conventional insurance (Aetna) - conventional insurance structures involve gharar (excessive uncertainty) and riba elements not permitted under Shariah frameworks.
• The company's capital structure relies on conventional interest-bearing debt (not sukuk or Shariah-compliant financing), with total debt exceeding $64B.

This report is provided purely for educational purposes and general understanding of the US market - not an investment recommendation for Shariah-focused investors. If you are a Muslim investor who strictly follows Shariah screening, CVS is automatically excluded from your investable universe regardless of any other data point.

This section is being refreshed with the latest figures. Please check back soon.

This section is being refreshed with the latest figures. Please check back soon.